✦ LIBER ✦

A Kent and Medway Cancer Network (KMCN) audit of second-line treatment for non-small cell lung cancer

✍ Scribed by Cafferkey, C.; Jamal-Hanjani, M.; Beesley, S.; Cominos, M.; Sevitt, T.; Taylor, H.; Burcombe, R.; Shah, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

19 A Kent and Medway Cancer Network (KMC

✍ Letsa, I.; Mikropoulos, C.; Burcombe, R.; Visioli, A.; Sevitt, T.; Cominos, M.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Second-Line Therapy for Non–Small-Cell L

✍ Belisario A. Arango; Aurelio B. Castrellon; Edgardo S. Santos; Luis E. Raez 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 131 KB

Second and third line treatment in non-s

✍ Adolfo Favaretto; Giulia Pasello; Cristina Magro; Clorinda Schettino; Cesare Gri 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Second- and third-line treatments in non

✍ Atul Kumar; Heather Wakelee 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 517 KB

Docetaxel in Second-Line Treatment of no

✍ Frank V. Fossella 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 142 KB

Second-line treatment for advanced non-s

✍ Barlési, Fabrice; Jacot, William; Astoul, Philippe; Pujol, Jean-Louis 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 158 KB